🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
17.58
-0.96 (-5.18%)
At close: Nov 20, 2026, 4:00 PM EST
18.00
+0.42 (2.39%)
After-hours: Nov 20, 2026, 7:30 PM EST

Caris Life Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
1,048812.03412.26306.13258.49
Revenue Growth
61.48%96.97%34.67%18.43%-
Cost of Revenue
322.12271231.83214.87178.46
Gross Profit
726.01541.04180.4391.2680.02
Selling, General & Admin
458.75396.37326.05296.04294.51
Research & Development
127.3399.56111.5114.77101.27
Operating Expenses
586.08495.93437.55410.81395.78
Operating Income
139.9445.11-257.12-319.55-315.76
Interest Expense
-42.64-56.85-50.03-31.61-26.68
Interest & Investment Income
2716.57.1211.260.95
Other Non Operating Income (Expenses)
0.48-52.9518.149.420.66
EBT Excluding Unusual Items
124.77-48.19-281.89-330.5-320.83
Other Unusual Items
-27.2-19.9--10.92-
Pretax Income
97.57-68.09-281.89-341.42-320.83
Net Income
96.06-68.09-281.89-341.42-320.83
Preferred Dividends & Other Adjustments
-469.8796.37121.1179
Net Income to Common
96.06-537.96-378.26-462.53-399.83
Net Income Growth
-----
Shares Outstanding (Basic)
283167353533
Shares Outstanding (Diluted)
292167353533
Shares Change
177.01%371.04%1.59%4.73%-
EPS (Basic)
0.34-3.22-10.66-13.24-11.98
EPS (Diluted)
0.33-3.22-10.66-13.24-11.98
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
28.9166.9-253.64-298.42-327.96
Free Cash Flow Per Share
0.100.40-7.15-8.54-9.83
Gross Margin
69.27%66.63%43.77%29.81%30.96%
Operating Margin
13.35%5.56%-62.37%-104.38%-122.16%
Profit Margin
9.16%-66.25%-91.75%-151.09%-154.68%
Free Cash Flow Margin
2.76%8.24%-61.52%-97.48%-126.88%
EBITDA
162.4467.73-208.21-270.55-267.5
EBITDA Margin
15.50%8.34%-50.50%-88.38%-103.49%
D&A For EBITDA
22.522.6248.914948.25
EBIT
139.9445.11-257.12-319.55-315.76
EBIT Margin
13.35%5.56%-62.37%-104.38%-122.16%
Revenue as Reported
1,048812.03412.26306.13258.49
Advertising Expenses
-3.61.20.61
SEC Filings: 10-K · 10-Q